- Home
- TCTM vs INDP Comparison
TCTM vs INDP Comparison
Compare TCTM & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCTM
- INDP
- Stock Information
- Founded
- TCTM 2002
- INDP 2000
- Country
- TCTM China
- INDP United States
- Employees
- TCTM N/A
- INDP N/A
- Industry
- TCTM Other Consumer Services
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- TCTM Real Estate
- INDP Health Care
- Exchange
- TCTM Nasdaq
- INDP Nasdaq
- Market Cap
- TCTM 14.3M
- INDP 12.1M
- IPO Year
- TCTM 2014
- INDP N/A
- Fundamental
- Price
- TCTM $0.88
- INDP $1.16
- Analyst Decision
- TCTM
- INDP Strong Buy
- Analyst Count
- TCTM 0
- INDP 2
- Target Price
- TCTM N/A
- INDP $8.50
- AVG Volume (30 Days)
- TCTM 10.9K
- INDP 305.3K
- Earning Date
- TCTM 01-01-0001
- INDP 11-12-2024
- Dividend Yield
- TCTM N/A
- INDP N/A
- EPS Growth
- TCTM N/A
- INDP N/A
- EPS
- TCTM 0.11
- INDP N/A
- Revenue
- TCTM $193,937,582.00
- INDP N/A
- Revenue This Year
- TCTM $99.90
- INDP N/A
- Revenue Next Year
- TCTM N/A
- INDP N/A
- P/E Ratio
- TCTM $4.94
- INDP N/A
- Revenue Growth
- TCTM N/A
- INDP N/A
- 52 Week Low
- TCTM $0.74
- INDP $1.03
- 52 Week High
- TCTM $2.99
- INDP $3.10
- Technical
- Relative Strength Index (RSI)
- TCTM 38.82
- INDP 43.45
- Support Level
- TCTM $0.95
- INDP $1.13
- Resistance Level
- TCTM $1.12
- INDP $1.31
- Average True Range (ATR)
- TCTM 0.07
- INDP 0.12
- MACD
- TCTM -0.01
- INDP -0.01
- Stochastic Oscillator
- TCTM 0.00
- INDP 17.39
About TCTM Tarena International Inc.
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has a single reportable segment: IT-focused Supplementary STEM Education Services. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.